Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINGO1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ADD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DPP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRASLS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRAMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRFIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMER2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLRG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM39-RPP21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNKS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD6-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on